<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/102F2A51-71E4-4ECA-A245-9B9C4858D7E4"><gtr:id>102F2A51-71E4-4ECA-A245-9B9C4858D7E4</gtr:id><gtr:name>MRC Harwell</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Clinical Medicine</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/102F2A51-71E4-4ECA-A245-9B9C4858D7E4"><gtr:id>102F2A51-71E4-4ECA-A245-9B9C4858D7E4</gtr:id><gtr:name>MRC Harwell</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/642A6BB7-AF02-4518-A376-107C0BB4D6D1"><gtr:id>642A6BB7-AF02-4518-A376-107C0BB4D6D1</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Croucher</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6433BAE5-5750-4CAF-B009-AD2597263DB8"><gtr:id>6433BAE5-5750-4CAF-B009-AD2597263DB8</gtr:id><gtr:firstName>Rajesh</gtr:firstName><gtr:surname>Thakker</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/ECC976E7-B6C0-415D-A8FA-FCBF275E7D27"><gtr:id>ECC976E7-B6C0-415D-A8FA-FCBF275E7D27</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:surname>Brown</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B7641D9F-ED26-4656-A4A2-758D48794A8E"><gtr:id>B7641D9F-ED26-4656-A4A2-758D48794A8E</gtr:id><gtr:firstName>Matthew</gtr:firstName><gtr:surname>Brown</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F22C9F56-9DA2-4473-8608-001C6A5F7C89"><gtr:id>F22C9F56-9DA2-4473-8608-001C6A5F7C89</gtr:id><gtr:firstName>Roger</gtr:firstName><gtr:otherNames>David</gtr:otherNames><gtr:surname>Cox</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600702"><gtr:id>F87B93BA-15A3-43A5-938B-E8D24300943A</gtr:id><gtr:title>A UK resource of new models of bone and mineral disorders</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600702</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>We propose to establish a UK consortium to perform an ethyl-nitrosourea (ENU) mutation screen to provide models of human musculoskeletal diseases including disorders of: bone quantity and mineralisation (e.g. osteoporosis and Paget?s disease), bone mineral homeostasis (e.g. parathyroid disease); urate metabolism; ectopic calcification and ossification; osteoarthritis; skeletal dysplasias, and tumours. 

ENU mutagenesis is an established method for the rapid, efficient development of novel mouse models for a better understanding of the genetic basis and the genetic pathways involved in human disease. Using efficient screening by digital radiography, dual-energy X-ray absorptiometry, microCT and serum biochemistry, mice will be screened for a wide range of musculoskeletal disorders. ENU gene-driven screens will also be performed to identify mice with mutations in ~ 12 candidate genes of interest. Over three years, 8,000 mice will be screened as part of the Harwell dominant mutagenesis programme. 3,000 mice will be screened as part of the Mary Lyon Centre?s (MLC) standard production pipeline of mutagenised mice for dominant genome-wide screens, involving mating mutagenised C57BL/6 males to C3H females and scoring the hybrid offspring. However, for bone mineral density (BMD) screens there are large differences in BMD between the BL/6 and C3H strains reflecting allelic variation at a variety of QTLs around the genome governing BMD. Therefore for these studies we will initially screen the F1 from mutagenised BL/6 males mated with BL/6 females, and following demonstration of heritability perform subsequent gene mapping employing two strains with similar whole body BMD e.g. BL/6 and DBA. A further 5,000 mice will be screened in this part of the study. In addition, we will screen approximately 50 lines from the MLC?s recessive genome-wide mutagenesis pipeline. 

Through this program we aim to establish a valuable resource for future research into the genetic causat common heritable musculoskeletal disorders.</gtr:technicalSummary><gtr:fund><gtr:end>2011-02-04</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-02-05</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1854524</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Harwell</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Mammalian Genetics Unit</gtr:department><gtr:description>Brown, S</gtr:description><gtr:id>C33718AB-6584-4358-BA15-F81F045FE6D5</gtr:id><gtr:impact>20457824</gtr:impact><gtr:outcomeId>GSMgUKwxpHb-1</gtr:outcomeId><gtr:partnerContribution>Brought together different expertise and resources to answer a biological question.</gtr:partnerContribution><gtr:piContribution>Undertaken molecular genetic studies and mouse phenotyping analysis together with details for publication.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>The Mary Lyon Centre</gtr:department><gtr:description>Cox, R</gtr:description><gtr:id>470D2670-079E-4B88-8FC7-A753D500DB24</gtr:id><gtr:impact>Several papers, full details under publications.</gtr:impact><gtr:outcomeId>mRNsk5K4gnZ-1</gtr:outcomeId><gtr:partnerContribution>Brought together different expertise and resources to answer a biological question.</gtr:partnerContribution><gtr:piContribution>Undertaken molecular genetic studies and mouse phenotyping analysis together with details for publication.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Commission</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>Treat-OA</gtr:description><gtr:id>9D29F1D3-9F9D-490B-9502-4F3F82F9512F</gtr:id><gtr:impact>Studies still in progress. Several abstract presented at British Endocrine Societies meeting and American Society of Bone and Mineral Research.</gtr:impact><gtr:outcomeId>F4F58893F0C-1</gtr:outcomeId><gtr:partnerContribution>Greater links with European investigators.</gtr:partnerContribution><gtr:piContribution>Providing models for osteoarthritis and basic science processes.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>194000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>Kidney Research UK</gtr:fundingOrg><gtr:id>F2B000BA-C15F-465A-A89F-9F19F444358B</gtr:id><gtr:outcomeId>tdkYEkdusPv</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Collabortive Grant</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>8E3AC45E-84B0-4073-A8AA-4E3CF8B30A02</gtr:id><gtr:outcomeId>THyV18zWyUN</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Treat-OA</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>725D9CA0-AFF9-418C-A85A-5FE75D8FFF12</gtr:id><gtr:outcomeId>pGKyj1u8veV0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship - C Gorvin</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>AAD85620-B91E-41A1-B466-2EB3DC737326</gtr:id><gtr:outcomeId>cFEfAxPZ9Fv0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Centre of Excellence Award</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:id>35534115-F61A-41BA-9740-2419073EA10D</gtr:id><gtr:outcomeId>tr8zHcqW6kP</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship - K Gaynor</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>E38EDA8A-A39C-4086-850A-47817D19756C</gtr:id><gtr:outcomeId>pXUanb7RJip0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>mouse models for musculoskeletal disorders</gtr:description><gtr:id>59B331BE-98B0-4F9B-B697-8C07B9E36B67</gtr:id><gtr:impact>Mouse models for musculoskeletal disease</gtr:impact><gtr:outcomeId>0AEA6A4BE3B</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>mouse models</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>1846D6AF-2EF9-4E05-AF24-4540134DB03F</gtr:id><gtr:title>Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a0481551021c409f7506d2f06ea4564"><gtr:id>9a0481551021c409f7506d2f06ea4564</gtr:id><gtr:otherNames>Duncan EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>fSeBsApcQmP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CDABC1D-0C07-4A2D-97C3-04B947B84FFF</gtr:id><gtr:title>Symmetrically reduced stiffness and increased extensibility in compression and tension at the mineralized fibrillar level in rachitic bone.</gtr:title><gtr:parentPublicationTitle>Bone</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/485fae73aaa56c4f03380b50f6866902"><gtr:id>485fae73aaa56c4f03380b50f6866902</gtr:id><gtr:otherNames>Karunaratne A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1873-2763</gtr:issn><gtr:outcomeId>pm_14810_20_23128355</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8276E145-6D8B-491D-89BB-6E9188679A3A</gtr:id><gtr:title>Hypophosphatemic rickets is associated with disruption of mineral orientation at the nanoscale in the flat scapula bones of rachitic mice with development.</gtr:title><gtr:parentPublicationTitle>Bone</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/485fae73aaa56c4f03380b50f6866902"><gtr:id>485fae73aaa56c4f03380b50f6866902</gtr:id><gtr:otherNames>Karunaratne A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1873-2763</gtr:issn><gtr:outcomeId>pm_14810_20_22609228</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4ACFCC5-727D-4550-8665-FD270FE701BC</gtr:id><gtr:title>Mouse models for inherited endocrine and metabolic disorders.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d1ac2130962ee63f2defcb9b59a8461"><gtr:id>9d1ac2130962ee63f2defcb9b59a8461</gtr:id><gtr:otherNames>Piret SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>rE92ZDirium</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BA7A08E-F0C6-4A9F-BE24-AADDB6EBCF59</gtr:id><gtr:title>N-ethyl-N-Nitrosourea (ENU) induced mutations within the klotho gene lead to ectopic calcification and reduced lifespan in mouse models.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fe10ebdb8ef07071e879e1ba8081ed4"><gtr:id>0fe10ebdb8ef07071e879e1ba8081ed4</gtr:id><gtr:otherNames>Esapa CT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_55f985985ddd6fb4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8244DC29-F3B6-44EE-975D-F9769872D090</gtr:id><gtr:title>Mice with an N-Ethyl-N-Nitrosourea (ENU) Induced Tyr209Asn Mutation in Natriuretic Peptide Receptor 3 (NPR3) Provide a Model for Kyphosis Associated with Activation of the MAPK Signaling Pathway.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fe10ebdb8ef07071e879e1ba8081ed4"><gtr:id>0fe10ebdb8ef07071e879e1ba8081ed4</gtr:id><gtr:otherNames>Esapa CT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58c6b0c0b94634.13841189</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A28E8BD-2BA2-4463-BFBD-52EBF0773461</gtr:id><gtr:title>Establishing normal plasma and 24-hour urinary biochemistry ranges in C3H, BALB/c and C57BL/6J mice following acclimatization in metabolic cages.</gtr:title><gtr:parentPublicationTitle>Laboratory animals</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ffdf89415bf00d701ee8134ddbdd49e"><gtr:id>1ffdf89415bf00d701ee8134ddbdd49e</gtr:id><gtr:otherNames>Stechman MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0023-6772</gtr:issn><gtr:outcomeId>ZskDekDPQdT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEDE94F6-C3C7-45E5-8B28-BD876589C254</gtr:id><gtr:title>A mouse model for spondyloepiphyseal dysplasia congenita with secondary osteoarthritis due to a Col2a1 mutation.</gtr:title><gtr:parentPublicationTitle>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fe10ebdb8ef07071e879e1ba8081ed4"><gtr:id>0fe10ebdb8ef07071e879e1ba8081ed4</gtr:id><gtr:otherNames>Esapa CT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0884-0431</gtr:issn><gtr:outcomeId>pm_14810_20_22028304</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F134B84-A7C3-4D15-9335-BA69FAFF7E08</gtr:id><gtr:title>Significant deterioration in nanomechanical quality occurs through incomplete extrafibrillar mineralization in rachitic bone: evidence from in-situ synchrotron X-ray scattering and backscattered electron imaging.</gtr:title><gtr:parentPublicationTitle>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/485fae73aaa56c4f03380b50f6866902"><gtr:id>485fae73aaa56c4f03380b50f6866902</gtr:id><gtr:otherNames>Karunaratne A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0884-0431</gtr:issn><gtr:outcomeId>pm_14810_20_22161748</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E49A823-C983-44D3-AA3C-CD0EF56A1414</gtr:id><gtr:title>A mouse with an N-Ethyl-N-nitrosourea (ENU) Induced Trp589Arg Galnt3 mutation represents a model for hyperphosphataemic familial tumoural calcinosis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fe10ebdb8ef07071e879e1ba8081ed4"><gtr:id>0fe10ebdb8ef07071e879e1ba8081ed4</gtr:id><gtr:otherNames>Esapa CT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14810_20_22912827</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E69362DE-08E6-4FDA-9144-81C2EDF1F492</gtr:id><gtr:title>An N-ethyl-N-nitrosourea induced corticotropin-releasing hormone promoter mutation provides a mouse model for endogenous glucocorticoid excess.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff9ff780a2c6c6c409cf9d75f12ebab5"><gtr:id>ff9ff780a2c6c6c409cf9d75f12ebab5</gtr:id><gtr:otherNames>Bentley L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>doi_55f9859856942fe6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>400ABFEE-F959-4BA3-87A4-AF454960B01D</gtr:id><gtr:title>Autosomal dominant hypercalciuria in a mouse model due to a mutation of the epithelial calcium channel, TRPV5.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4afd07a38cd306c5f99be9de1030ef21"><gtr:id>4afd07a38cd306c5f99be9de1030ef21</gtr:id><gtr:otherNames>Loh NY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14810_20_23383183</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2981D430-ED15-40C4-8795-AA62E14635B3</gtr:id><gtr:title>Multiscale alterations in bone matrix quality increased fragility in steroid induced osteoporosis.</gtr:title><gtr:parentPublicationTitle>Bone</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/485fae73aaa56c4f03380b50f6866902"><gtr:id>485fae73aaa56c4f03380b50f6866902</gtr:id><gtr:otherNames>Karunaratne A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-2763</gtr:issn><gtr:outcomeId>585d5518d1a1c9.28985909</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600702</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>